Thomas Deschamps

Partner, Finance & Commercialization

  • Managing Director and Portfolio Manager at Healthcare Value Capital, llc (former Bear Stearns asset management), manages a portfolio of $100m healthcare hedge fund and  responsible for all aspects of portfolio construction and risk management.
  • Board of Director’s member at Blue Ash Therapeutics, llc, has led $1.6m seed investment for privately held specialty pharmaceutical company in july 2010.
  • Managing director, equity research pharmaceuticals at Bear Stearns & Company, initiated lead coverage on several specialty pharmaceutical stocks including; MDCO, SCIO (acquired), PHRM (acquired), and BCII (acquired). Assisted Riccardo/Shevick research team in coverage of pharmaceutical industry.
  • Analyst, specialty pharmaceuticals at Mehta Partners, llc  responsible for sell-side coverage of US And EU in the Specialty pharmaceutical sector. Generated stock ideas for $100m internal hedge fund.
  • Sales executive Mwg Biotech, Biosource International (Invitrogen corp)   
  • Research Technician at Memorial Sloan-Kettering Cancer Center and at Cornell University Medical College

“When you combine great products with exceptional individuals you have caught lightning in a bottle.”